Advertisement

BMC Infectious Diseases

, 19:585 | Cite as

The burden of antimicrobial resistance at tertiary care hospital, southern Ethiopia: a three years’ retrospective study

  • Tsegaye AlemayehuEmail author
  • Mulubrahan Ali
  • Enkosilassie Mitiku
  • Mengistu Hailemariam
Open Access
Research article
Part of the following topical collections:
  1. Bacterial and fungal diseases

Abstract

Background

Antibiotic resistance is a worldwide problem that crosses international boundaries and spread between continents easily. Hence, information on the existence of the causative microorganisms and their susceptibility to commonly used antibiotics are essential to enhance therapeutic outcome.

Method

A cross-sectional study was conducted retrospectively at Hawassa University Comprehensive Specialized Hospital. The culture and antibiotic sensitivity data of the isolates were collected from the record books of the microbiology unit for the study period after official permission obtained from the institutional review board. The data entered and analyzed using statistical package for social science software version 20.

Result

A total of 693 bacteria were retrieved, of these 435(62.77%) were gram-negative and the rest 258(37.23%) were gram-positive. Most of the isolates were from a urine sample. Among gram positives isolates, S. aureus and from gram negatives Klebsiella spp are the most recurrent isolate. Almost a remarkable resistance was observed to most of the antibiotics mainly, penicillin G (81.8%) and cotrimoxazole (81.1%), for gram-positive bacteria. The gram-negative bacteria also show resistance to ampicillin (92.5%), tetracycline (85%) and cotrimoxazole (93.1%).

Conclusions

Nearly all isolate show substantial rates of resistance to most of the antibiotic that is frequently used in the study area. As already known we want to emphases on the importance of performing continuous monitoring of drug susceptibility to help the empirical treatment of bacterial agents to a health professional in the region. In addition, this data might help policymakers to control of antibiotics resistance.

Keywords

Antibiotics resistance Clinical samples Southern Ethiopia 

Abbreviations

AMR

Antimicrobial Resistance

ATCC

American type culture collection

CLSI

Clinical and laboratory standard Institute

CoNS

Coagulase-negative staphylococcus

CSF

Cerebrospinal fluid

ESBL

Extended-spectrum ß-lactamase

GNB

Gram-negative bacteria

GPB

Gram-positive bacteria

HUCSH

Hawassa University Comprehensive Specialized Hospital

IRB

Institutional Review Board

MDR

Multi-drug resistance

MRSA

Methicillin-resistant S. auraes

PYRase

Pyrrolidonyl arylamidase

SNNPR

Southern Nation Nationalities’ and peoples’ region

SOP

Standard operating procedure

SPSS

Statistical package for social sciences

Background

Antibiotic resistance is a worldwide problem that can cross international boundaries and spread between continents with ease [1, 2]. The introduction of antibiotics in the mid-twentieth century was an important medical event in history with regard to reducing human and livestock morbidity and mortality. However, the subsequent and continuing intensive use of antibiotics since their introduction has helped to select a huge increase in the frequency of resistance among human pathogens [3]. Antibiotic resistance results in reduced efficacy of antibacterial agents make the treatment of patients difficult, costly, or even impossible. The impact on susceptible patients is most obvious, resulting in prolonged illness and even mortality. The magnitude of the problem and the impact of antimicrobial resistance (AMR) on human health including on costs for the health-care due to AMR still largely need further investigation [4].

The antibiotic resistance crisis has been attributed to the overuse and misuse of medications, as well as a lack of new drug development by the pharmaceutical industry due to reduced economic incentives and challenging regulatory requirements [5, 6]. In high-income countries, continued high rates of antibiotic use in hospitals contributed to selection pressure that has sustained resistant strains, forcing a shift to more expensive and more broad-spectrum antibiotics [6]. In low-income countries, divers antibiotic usage increases time to time due to high rates of hospitalization, and the high rate of infectious disease [6, 7].

On the other hand, the emergence of multidrug-resistant bacteria is a challenge for physicians to manage critical patients [8]. As already known, methicillin-resistant s. aureus (MRSA), extended-spectrum ß-lactamase (ESBL) E. coli, vancomycin-resistant s. aureus and enterococcus associated morbidity and mortality are global problems [9, 10]. In regard to our setup, drug resistance to be expected as a major challenge even though there is no local report as well drug resistance monitoring system. Therefore, the aim of this study was to determine the burden of antibiotic resistance patterns by analyzing data collected retrospectively of a period of 3 years at the Hawassa University Comprehensive Specialized Hospital (HUCSH) in southern Ethiopia.

Methods

This study design was an institution based cross-sectional study from November 2014–November 2017 retrospectively. The study was conducted on all clinical sample sent to the microbiology lab of HUCSH, Hawassa, Ethiopia. Hawassa is a city in Ethiopia, on the shores of Lake Hawassa in the Great Rift Valley. It is located 270 km south of Addis Ababa via Debre Zeit. The town serves as the capital of the Southern Nations, Nationalities, and Peoples’ Region (SNNPR). It lies on the Trans-African Highway to Cairo-Cape Town, and has a latitude and longitude of 7° 3′ 35 “ N and of 38° 28’ 11” E. It has an elevation of 1708 m above sea level [11].

The HUCSH serves as a referral centre for both public and private hospitals in South Regional State also for the neighbouring region. The hospital was established in November 2005 and serves about 12 million people in the Southern Nation, Nationalities’ and peoples’ region (SNNPR) and neighbouring Oromia. Besides providing clinical services, the hospital is a teaching hospital for medical and paramedical students. It is located 273 km south of the capital city, Addis Ababa. The microbiology laboratory at HUCSH was established in 2010. It is the only laboratory in the region that participates in obtaining accreditation.

Patient data were reviewed by the principal investigators using a designed chart. Thus, all cultured sample of the patient and appropriate information were retrieved from the microbiology laboratory unit registration book. Age, sex, specimen type, bacterial isolates and antibiotic susceptibility pattern were collected using a data extraction sheet. Those with incomplete data that means a data which was not recorded for either of the isolated organism, antibiotics susceptibility, unknown sample type, sex and age were excluded. Statistical package for social sciences (SPSS) version 20 was used for both data entry and analysis. Descriptive statistics were used to determine the frequency of isolated bacteria.

The microbiological lab performs culture and sensitivity test from the urine, puss, blood, ear discharge, eye swab, genital swab, stool, cerebrospinal fluid (CSF), sputum and nasal swab sample suspected for any bacterial infection based on the standard operating procedure (SOP). The samples were sent from different wards however the samples address was not recorded in the laboratory book. All samples were cultured on appropriate culture media i.e. manual blood culture was conducted whenever a blood-stream infection is suspected in trypticase soy broth prepared in the laboratory. If there is an indication of growth like hemolysis, gas, and turbidity the inoculum was subcultured on appropriate solid medium for further identification. Blood and MacConkey agar were used to culture non-fastidious bacteria and Chocolate agar included for fastidious bacteria and Thayer Martin agar for the genital sample was used. The single bacterial colony from culture media was taken for gram staining. Based on the gram reaction biochemical tests selected. Gram-positive bacteria are identified using catalase, coagulase, bacitracin, pyrrolidonyl arylamidase (PYRase), optochin bile solubility and Novobiocin. Gram-negative bacterial was identified based on serial biochemical reactions and fermentation of carbohydrates i.e. oxidase, catalase, triple sugar iron agar, citrate utilization test, urease, lysine iron agar, sulphur indole motility, mannitol fermentation, and indole test. Gram staining and colony characteristic were used for preliminary identification of the bacteria. Some bacterial were identified to species level by biochemical and some of them to genus level by morphological characteristics (grams stain and colony characteristics). The antibiotic sensitivity pattern was determined with the Kirby-Bauer disc diffusion technique and interpreted based on the current clinical and laboratory standard Institute (CLSI) 2014–2017 guideline.

The susceptibility testing was conducted based on the recommendation of the CLSI. Different antibiotic discs (Abtek LTD, UK) were used: Ampicillin (AMP)(10 μg), gentamicin-Gen(10 μg), ciprofloxacin-CRP(5 μg), ceftriaxone-CRT(30 μg), ceftazidime-CAZ(30 μg), norfloxacin-NOR)(10 μg), nitrofurantoin-NIT(300 μg), augmentin-AUG(20/10 μg), cotrimoxazole-COT(1.25/23.75 μg), chloramphenicol-CAF(30 μg), meropenem-MER(10 μg), tetracycline-TAT(30 μg), penicillin G-PEN(10 IU), Clindamycin-CLD(2 μg) and erythromycin-ERY(15 μg).

Quality control

The microbiology lab performs quality control of all culture system by using E. coli (ATCC-25922), S. aureus (ATCC- 25923) and P. aeruginosa (ATCC-27853) which was ordered and supervised by the national lab of Ethiopia.

Ethical consideration

Ethical clearance was obtained from, Institutional Review Board (IRB) of Hawassa University College of Medicine and Health Sciences. Besides official permission was obtained from the hospital administration to collect the information from the registration book. Patients’ data were anonymized and kept confidential throughout this study. All data obtained in the course of the study were reserved confidential and used only for this study.

Results

Percentage of total isolates within age and sex

A total of 693 bacteria were included for the study from different clinical specimens (blood, urine, puss, genital swab, eye swab, ear discharge, sputum, nasal swab, body fluids, CSF and stool). Of these 435(62.8%) were gram-negative bacteria (GNB) and the rest 258(37.2%) were gram-positive bacteria (GPB). Most of the isolates were detected in children less than 5 years of age (48.2%; 334/693) followed by 24–64 years of age (21.2%; 147/693); the least number of isolates were found from patients > 64 years of age. Most of the isolates were from male patients with a male to female ratio 1.13:1 (Table 1).
Table 1

Age and sex distribution of patients with bacterial isolates, HUCSH, Southern Ethiopia

Age group in year

Sex

Total Bacteria (%)

Male N (%)

Female N (%)

< 5

189(51.2)

145(44.8)

334(48.2)

5–14

62(16.8)

68(21)

130(18.8)

14–24

33(8.9)

29(9)

62(8.9)

24–64

74(20.1)

73(22.5)

147(21.2)

> 64

11(3)

9(2.8)

20(2.9)

Total

369(100)

324(100)

693(100)

Sample type and bacterial isolates

Regarding sample type, most of the isolates were from urine sample 251(36.2%) followed by puss sample 190(27.4%) and blood 131(18.9%). When we observe the frequency of isolates; S. aureus was the leading 156(22.5%) and S. pneumoniae 7(1%) was the least from gram-positive bacteria. Klebsiella spp 154(22.2%) were the predominant isolates and N. gonorrhoea 3(0.4%) was the least from gram-negative bacteria (Table 2).
Table 2

Distribution of sample type and bacterial isolates from a study of the burden of antimicrobial resistance at HUCSH, southern Ethiopia

    

Specimen type

      

Total

Isolates

Urine

Body Fluids

Stool

Ear Swab

Eye swab

CSF

Blood

Sputum

Puss

Nasal swab

Genital swab

 

S. auraes

22(8.8)

6(31.6)

0

5(11.9)

6(50)

0

19(14.5)

1(5.9)

97(51.1)

0

0

156(22.5)

CoNS

9(3.6)

0

0

0

0

0

55(42)

0

0

0

0

64(9.2)

Enterococcus spp

17(6.8)

1(5.3)

0

0

1(8.3)

0

10(7.6)

1(5.9)

1(0.5)

0

0

31(4.5)

S. pneumonia

0

0

0

3(7.1)

0

1(14.3)

3(2.3)

0

0

0

0

7(1)

Klebsiella spp

79(31.5)

5 (26.3)

0

9(21.4)

2(16.7)

0

26(19.8)

8(47.1)

25(13.2)

0

0

154(22.2)

E. coli

70(27.9)

2(10.5)

0

9(21.4)

1(8.3)

2(28.6)

5(3.8)

0

26(13.7)

1 (50)

0

116(16.7)

Pseudomonas spp

11(4.4)

1(5.3)

0

9(21.4)

0

0

7(5.3)

3(17.6)

15(7.9)

1 (50)

0

47(6.8)

Citrobacter spp

16(6.4)

3(15.8)

0

2(4.8)

1(8.3)

0

1(0.8)

2(11.8)

7(3.7)

0

0

32(4.6)

Enterobacter spp

16(6.4)

0

0

0

1(8.3)

0

2(1.5)

1(5.9)

4(2.1)

0

0

24(3.5)

Acinetobacter spp

4(1.6)

0

0

1(2.4)

0

0

2(1.5)

1(5.9)

10(5.3)

0

0

18(2.6)

Proteus Spp

6(2.4)

1(5.3)

0

4(9.5)

0

0

0

0

5(2.6)

0

0

16(2.3)

Shigella spp

0

0

12(63.2)

0

0

0

0

0

0

0

0

12(1.7)

Salmonella spp

1(0.4)

0

7(36.8)

0

0

0

1(0.8)

0

0

0

0

9(1.3)

N. meningitis

0

0

0

0

0

4(57.1)

0

0

0

0

0

4(0.6)

N. gonorrhea

0

0

0

0

0

0

0

0

0

0

3(100)

3(0.4)

Total

251(36.2)

19(2.7)

19(2.7)

42(6.1)

12(1.7)

7(1)

131(18.9)

17(2.5)

190(27.4)

2(0.3)

3(0.4)

693(100)

Antibiotics resistance patterns of GPB

Concerning antibiotics resistance, we can say that extraordinarily resistant were recorded for cotrimoxazole, penicillin G, norfloxacin and ceftazidime by most of the gram-positive bacteria. In the other hand least resistance was recorded for nitrofurantoin (Table 3).
Table 3

Antibiotics resistance patterns of GPB, HUCSH, and Southern Ethiopia

Antibiotics

S. aureus (156)

CoNS (64)

Enterococcus spp(31)

S. pneumoniae (7)

Total

R (%)

R (%)

R (%)

R (%)

R (%)

AMP

NR

NR

20(74.1)

NR

20(74.1)

GEN

42(31.8)

32(55.2)

NR

NR

74(38.9)

COT

61(73.5)

49(90.7)

NR

4(66.7)

116(81.1)

PEN

41(80.4)

24(92.3)

6(75)

1(33.3)

72(81.8)

CAF

22(19.5)

22(40.7)

8(34.8)

3(60)

55(28.2)

CLD

2(5.3)

ND

NR

NR

2(5.3)

NOR

15(65.2)

3(33.3)

10(83.3)

NR

28(63.6)

NIT

1(14.3)

ND

1(12.5)

NR

2(13.3)

ERY

20(31.7)

9(50)

11(73.3)

0(0)

40(40.4)

TAT

11(61.1)

ND

3(100)

0(0)

14(63.6)

CIP

42(31.8)

27(46.6)

19(76)

NR

88(40.9)

AUG

51(52)

24(39.3)

NR

NR

75(47.2)

CTR

39(45.3)

22(41.5)

NR

NR

61(43.9)

CAZ

27(58.7)

31(79.5)

NR

ND

58(68.2)

NR- Not recommended, ND-not done, R-Resistance, T- total tested, CoNS- coagulase-negative staphylococcus, ampicillin (AMP)(10 μg), gentamicin-Gen(10 μg), ciprofloxacin-CRP(5 μg), ceftriaxone-CRT(30 μg), ceftazidime-CAZ(30 μg), norfloxacin-NOR)(10 μg), nitrofurantoin-NIT(300 μg), augmentin-AUG(20/10 μg), cotrimoxazole-COT(1.25/23.75 μg), chloramphenicol-CAF(30 μg), meropenem-MER(10 μg), tetracycline-TAT(30 μg), penicillin G-PEN(10 IU), Clindamycin-CLD(2 μg) and erythromycin-ERY(15 μg).

Antibiotics resistance patterns of Enterobacteriaceae

Again higher resistance was reported from Enterobacteriaceae. As shown in Table 4 ampicillin (92.5%), cotrimoxazole (85%) and tetracycline (85%) was substantially resisted antibiotics.
Table 4

Antibiotics resistance patterns of Enterobacteriaceae, HUCSH Southern Ethiopia

Antibiotics

E. coli (116)

Klebsiella spp (154)

Enterobacter spp (24)

Citrobacter spp (32)

Proteus spp (16)

Shigella spp (12)

Salmonella spp (9)

Total

 

R (%)

R (%)

R (%)

R (%)

R (%)

R (%)

R (%)

R (%)

AMP

84(92.3)

106(93.8)

17(94.4)

21(91.3)

8(88.9)

6(75)

5(100)

247(92.5)

GEN

55(55.6)

107(79.3)

15(78.9)

16(61.5)

7(50)

4(40)

3(50)

207(67)

CRP

51(48.1)

57(41.3)

8(38.1)

6(22.2)

5(55.6)

2(25)

3(33.3)

132(41.5)

CTR

50(66.7)

97(86.6)

10(83.3)

14(63.6)

8(61.5)

5(50)

4(50)

188(74.6)

CAZ

28(56)

46(78)

4(66.7)

3(37.5)

2(40)

2(100)

1(100)

86(65.6)

NOR

46(61.3)

35(43.8)

8(47.1)

6(31.6)

4(66.7)

ND

100(50.8)

NIT

1(3.8)

1(7.1)

1(11.1)

1(16.7)

1(100)

ND

0(0)

5(8.7)

AUG

65(65.7)

93(74.4)

14(82.4)

15(60)

5(38.5)

4(50)

4(57.1)

200(68)

COT

51(81)

86(91.5)

14(82.4)

6(54.5)

5(83.3)

4(80)

4(100)

170(85)

CAF

26(36.6)

51(51)

5(50)

8(42.1)

4(50)

3(42.9)

3(42.9)

100(45.1)

MER

0(0)

3(13.6)

5(62.5)

2(42.9)

0(0)

ND

0(0)

11(22.9)

TAT

6(100)

4(100)

3(60)

4(100)

0(0)

ND

ND

17(85)

ND-Not done, R-Resistance, ampicillin (AMP)(10 μg), gentamicin-Gen(10 μg), ciprofloxacin-CRP(5 μg), ceftriaxone-CRT(30 μg), ceftazidime-CAZ(30 μg), norfloxacin-NOR)(10 μg), nitrofurantoin-NIT(300 μg), augmentin-AUG(20/10 μg), cotrimoxazole-COT(1.25/23.75 μg), chloramphenicol-CAF(30 μg), meropenem-MER(10 μg), tetracycline-TAT(30 μg)

Antibiotics resistance patterns of gram negatives non-Enterobacteriaceae

Likewise, a remarkable resistance for tested antibiotics was recorded by most non- Enterobacteriaceae isolates. As shown in Table 5 tetracycline (100%), cotrimoxazole (93.1%) and ampicillin (92.9%), was mainly resisted antibiotics.
Table 5

Antibiotics resistance patterns of non- Enterobacteriaceae group at HUCSH, Southern Ethiopia

Antibiotics

Pseudomonas spp (47)

Acinetobacter spp (18)

N. gonorrhoea (3)

N. meningitis (4)

Total

 

R (%)

R (%)

R (%)

R (%)

R (%)

Amp

23(92)

15(88.2)

NR

ND

39(92.9)

Gen

22(55.2)

11(84.6)

NR

ND

33(62.2)

CRP

14(32.6)

9(56.2)

2(100)

2(50)

27(41.5)

CTR

23(67.6)

10(76.9)

2(66.7)

1(100)

38(71.7)

CAZ

10(47.6)

3(75)

1(100)

1(100)

15(55.6)

NOR

3(25)

3(60)

NR

ND

7(41.2)

AUG

24(85.7)

11(78.6)

NR

1(100)

36(83.7)

COT

15(88.2)

10(100)

NR

1(50)

27(93.1)

CAF

14(70)

10(83.3)

NR

2(100)

26(76.5)

MER

2(50)

2(50)

NR

ND

4(50)

TAT

3(100)

2(100)

ND

NR

5(100)

ND-not done, NR-not recommended, ampicillin (AMP)(10 μg), gentamicin-Gen(10 μg), ciprofloxacin-CRP(5 μg), ceftriaxone-CRT(30 μg), ceftazidime-CAZ(30 μg), norfloxacin-NOR)(10 μg), nitrofurantoin-NIT(300 μg), augmentin-AUG(20/10 μg), cotrimoxazole-COT(1.25/23.75 μg), chloramphenicol-CAF(30 μg), meropenem-MER(10 μg), tetracycline-TAT(30 μg).

Multi-drug resistance pattern

Multi-drug resistance (MDR) is defined as resistance to at least one or more agents in three or more antibiotics categories [12]. Overall MDR to all isolates were (75.5%). Of this Klebsiella spp had been with highest MDR which was (87.7%) followed by Enterococcus spp (83.9%), Acinetobacter spp (83.3%), Enterobacter spp (83.3%) and Pseudomonas spp (80.9%). Least MDR was identified from S. aureus (57.7%) followed by S. pneumoniae (57.1%), Proteus spp (62.5%) and (66.7%) for each of these isolates (Salmonella spp, Shigella spp and N. gonorrhoea) (Fig.1).
Fig. 1

Multi-drug resistance in a study of the burden of antimicrobial resistance at HUCSH

Discussion

Antimicrobial resistance is one of the most serious problems faced the world nowadays. The lack of effective antibiotics will challenge healthcare workers to combat infectious diseases including their potential to manage complications, especially among immunocompromised clients. In this study, gram-negative bacteria were predominantly isolated from most specimens. The finding is similar to the studies reported from Southwest and Debre Markos. Ethiopia reported regardless of specimen type difference [13, 14]. The most frequently isolated gram-positive bacterium was S. aureus and the lest frequently isolated bacterium was S. pneumoniae which is in-line with a study conducted in Debre Markos on the clinical specimen and Bahir Dar from nosocomial infected patients in Ethiopia [14, 15] and in India from clinical specimen [16]. In the other hand Klebsiella, spp were the predominant gram-negative bacteria in our study, in-line with our finding studies from India reported the same [17]. In contrast to our study, E. coli were reported as dominant bacteria from India from clinical specimen conducted retrospectively [16] which can be explained by study area, period and individual difference.

Our finding indicated that extraordinary rates of resistance for most antibiotics. Specifically, gram-positive bacteria were resistant to ampicillin, cotrimoxazole and penicillin G which is in agreement with reports from Debre Markos [14] and Addis Ababa, Ethiopia [18], Ardabil, Iran [19], Gabon, Central Africa [10] and South East Nigeria [20]. Even though there is a difference in the study area and period, the amount of sample analyzed and a number of bacterial isolates captured.

Gram-negative bacteria had a remarkable rate of resistance to most antibiotics other studies from Addis Ababa, Ethiopia [21], Saudi Arabia [22], and Libya [23] agreed with our study as gram-negative bacteria (GNB) are more resisted as compared to GPB. On the other hand, low rates of resistance for all Enterobacteriaceae was observed to nitrofurantoin and meropenem in-line with studies from Bahir Dar, Ethiopia [24], Benin Nigeria [25].

Concerning non- Enterobacteriaceae, a high rate of resistance were observed to tetracycline, cotrimoxazole, ampicillin, amoxicillin-clavulanic acid, chloramphenicol and gentamicin. This resistance may be due to Pseudomonas spp and Acinetobacter spp which are the most common known resistant because of their nature of resistance for different chemical agents. Other studies supported this finding as high resistance Pseudomonas Spp from Iran [26], Dhaka [27], Nigeria [28], and Taiwan [29].

In our study we identified (57.1–87.3%) MDR, this showed that there are a few options to treat patients in the study area. Which was almost similar to others finding like, Studies reported from Mexico [30], Ethiopia [31], Hungary [32]. In general, we can say that antibiotics resistance will be a great challenge in the study area if there is no appropriate solution set on time.

Limitation of the study

 ✓ This study is a retrospective study so could not explain the current antimicrobial patterns in the study area.

✓ The study did not determine the resistance detected was due to hospital-acquired or community acquired infection.

✓ The study did not show the trends of antibiotics resistance from year to year.

Conclusions

This retrospective study identified revealed that nearly all the isolated bacteria developed substantial rates of resistance to most of the antibiotics that are frequently used in the study area. To some extent, gentamicin, ciprofloxacin, clindamycin, nitrofurantoin and chloramphenicol were effective to treat GPB, whereas penicillin G, cotrimoxazole, augmentin, ampicillin, norfloxacin, ceftazidime and tetracycline were the least effective antibiotics. Therefore, in general, the antibiotic-resistant rate is high in the specified study area, the physician should prescribe antibiotics based on drug susceptibility report. In case of the empirical treatment is mandatory prescribing antibiotics with less resistance may be helpful to manage bacterial infections. We hope also that these studies finding will help policymakers nationally as the best data for developing intervention measures and to exclude most resistant drugs from the market.

Notes

Acknowledgements

We would like to thanks Hawassa university comprehensive specialized hospital for official permission of this study and microbiology staffs for helping during data collection.

Ethics approval and consent to participation

The research was ethically approved by IRB of Hawassa University College of Medicine and health sciences. Permission for data collection was obtained from the hospital laboratory manager. Patients’ data were anonymized and kept confidential throughout this study. All data obtained in the course of the study were reserved confidential and used only for this study.

Competing of interests

The authors declare that they have no competing interests.

Authors’ contributions

TA, MA, EM and MH conceived the idea, develop the proposal, collected the data, perform the analysis and prepared the manuscript, MH has made final edition of the document. All authors have read and approved the manuscript.

Funding

No funding was received to perform this study.

Consent for publication

Not applicable.

References

  1. 1.
    World Health Organization. WHO global strategy for containment of antimicrobial resistance. No WHO/CDS/CSR/DRS/2001.2. Geneva: World Health Organization. 2001.Google Scholar
  2. 2.
    Choffnes ER, Relman DA, Mack A. Antibiotic resistance: implications for global health and novel intervention strategies. Workshop summary. In: Antibiotic resistance: implications for global health and novel intervention strategies Workshop summary: 2010: National Academies Press; 2010.Google Scholar
  3. 3.
    Andersson DI, Hughes D. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev. 2011;35(5):901–11.CrossRefGoogle Scholar
  4. 4.
    Shankar PR, Balasubramanium R. Antimicrobial resistance: global report on surveillance 2014. Australasian Medical Journal (Online). 2014;7(5):237.Google Scholar
  5. 5.
    Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. Pharmacol Ther. 2015;40(5):344.Google Scholar
  6. 6.
    Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–98.CrossRefGoogle Scholar
  7. 7.
    Laxminarayan R, Heymann DL. Challenges of drug resistance in the developing world. BMJ. 2012;344:e1567.CrossRefGoogle Scholar
  8. 8.
    Ayinalem GA, Gelaw BK, Belay AZ, Linjesa JL. Drug use evaluation of ceftriaxone in the medical ward of Dessie referral hospital, north East Ethiopia. International Journal of Basic & Clinical Pharmacology. 2017;2(6):711–7.CrossRefGoogle Scholar
  9. 9.
    Amato-Gauci A. Annual epidemiological report on communicable diseases in Europe: report on the status of communicable diseases in the EU and EEA/EFTA countries: European Centre for Disease Prevention and Control; 2007.Google Scholar
  10. 10.
    Alabi AS, Frielinghaus L, Kaba H, Kösters K, Huson MA, Kahl BC, Peters G, Grobusch MP, Issifou S, Kremsner PG. Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa. BMC Infect Dis. 2013;13(1):455.CrossRefGoogle Scholar
  11. 11.
    Bureau SNaNaPRSCaT: The General Background of the Southern Nations, Nationalities and Peoples' Regional State. 2019, http://www.southtourism.gov.et/?q=background.
  12. 12.
    Magiorakos AP, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C, Harbarth S, Hindler J, Kahlmeter G, Olsson-Liljequist B. Multidrug-resistant, extensively drug-resistant and pan-drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.CrossRefGoogle Scholar
  13. 13.
    Mama M, Abdissa A, Sewunet T. Antimicrobial susceptibility pattern of bacterial isolates from wound infection and their sensitivity to alternative topical agents at Jimma University specialized hospital, south-West Ethiopia. Ann Clin Microbiol Antimicrob. 2014;13:14.CrossRefGoogle Scholar
  14. 14.
    Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D. Bacterial agents and antibiotic resistance profiles of infections from different sites that occurred among patients at Debre Markos referral hospital, Ethiopia: a cross-sectional study. BMC Res Notes. 2017;10(1):254.CrossRefGoogle Scholar
  15. 15.
    Mulu W, Kibru G, Beyene G, Damtie M. Postoperative nosocomial infections and antimicrobial resistance pattern of bacteria isolates among patients admitted at Felege Hiwot referral hospital, Bahirdar, Ethiopia. Ethiop J Health Sci. 2012;22(1):7–18.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Divyashanthi C, Adithiyakumar S, Bharathi N. Study of prevalence and antimicrobial susceptibility pattern of bacterial isolates in a tertiary care hospital. Int J Pharm Pharm Sci. 2015;7(1):185–90.Google Scholar
  17. 17.
    Paul R, Ray J, Sinha S, Mondal J. Antibiotic resistance pattern of bacteria isolated from various clinical specimens: an eastern Indian study. 2017. 2017;4(4):5.Google Scholar
  18. 18.
    Dilnessa T, Bitew A. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 hospital medical college, Addis Ababa Ethiopia. BMC Infect Dis. 2016;16:398.CrossRefGoogle Scholar
  19. 19.
    Dibah S, Arzanlou M, Jannati E, Shapouri R. Prevalence and antimicrobial resistance pattern of methicillin-resistant Staphylococcus aureus (MRSA) strain isolated from clinical specimens in Ardabil Iran. Iranian Journal of Microbiology. 2014;6(3):163–8.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Nsofor C, Nwokenkwo V, Ohale C. Prevalence and antibiotic susceptibility pattern of Staphylococcus aureus isolated from various clinical specimens in south-East Nigeria. MOJ Cell Sci Rep. 2016;3(2):60–3.Google Scholar
  21. 21.
    Kabew G, Abebe T, Miheret A. A retrospective study on prevalence and antimicrobial susceptibility patterns of bacterial isolates from urinary tract infections in Tikur Anbessa specialized teaching hospital Addis Ababa, Ethiopia, 2011. Ethiop J Health Dev. 2013;27(2):111–7.Google Scholar
  22. 22.
    Haseeb A, Faidah HS, Bakhsh AR, Al Malki WH, Elrggal ME, Saleem F, ur Rahman S, Khan TM, Hassali MA. Antimicrobial resistance among pilgrims: a retrospective study from two hospitals in Makkah, Saudi Arabia. Int J Infect Dis. 2016;47:92–4.CrossRefGoogle Scholar
  23. 23.
    Mohammed MA, Alnour TM, Shakurfo OM, Aburass MM. Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata central hospital. Asian Pacific journal of tropical medicine Libya. 2016;9(8):771–6.CrossRefGoogle Scholar
  24. 24.
    Alabi AS, Frielinghaus L, Kaba H, Kosters K, Huson MA, Kahl BC, Peters G, Grobusch MP, Issifou S, Kremsner PG, et al. Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa. BMC Infect Dis. 2013;13:455.CrossRefGoogle Scholar
  25. 25.
    Ahoyo TA, Bankole HS, Adeoti FM, Gbohoun AA, Assavedo S, Amoussou-Guenou M, Kinde-Gazard DA, Pittet D. Prevalence of nosocomial infections and anti-infective therapy in Benin: results of the first nationwide survey in 2012. Antimicrob Resist Infect Control. 2014;3:17.CrossRefGoogle Scholar
  26. 26.
    Babakhani S, shokri Derikvand S, Nazer MR, Kazemi MJ. Comparison frequency and determination antibiotic resistance pattern of Klebsiella SPP. isolated from nosocomial infection in Khorramabad Shohadaye Ashayer hospital. Bull Env Pharmacol Life Sci. 2014;3:149–54.Google Scholar
  27. 27.
    Hoque MM, Ahmad M, Khisa S, Uddin MN, Jesmine R. Antibiotic resistance pattern in pseudomonas aeruginosa isolated from different clinical specimens. Journal of Armed Forces Medical College, Bangladesh. 2016;11(1):45–9.CrossRefGoogle Scholar
  28. 28.
    Igbalajobi O, Oluyege A, Oladeji A, Babalola J: Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from clinical samples in Ekiti State University teaching hospital, Ado-Ekiti, Ekiti State of Nigeria. British Microbiology Research Journal 2016, 12(4).CrossRefGoogle Scholar
  29. 29.
    Hsueh PR, Tseng SP, Teng LJ, Ho SW. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clin Microbiol Infect. 2005;11(8):670–3.CrossRefGoogle Scholar
  30. 30.
    Cornejo-Juarez P, Vilar-Compte D, Perez-Jimenez C, Namendys-Silva SA, Sandoval-Hernandez S, Volkow-Fernandez P. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infect Dis. 2015;31:31–4.CrossRefGoogle Scholar
  31. 31.
    Mengesha RE, Kasa BG-S, Saravanan M, Berhe DF, Wasihun AG. Aerobic bacteria in post-surgical wound infections and pattern of their antimicrobial susceptibility in Ayder teaching and referral hospital, Mekelle, Ethiopia. BMC Research Notes. 2014;7:575.CrossRefGoogle Scholar
  32. 32.
    Caini S, Hajdu A, Kurcz A, Borocz K. Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 20052010. Euro Surveill. 2013;18(2).Google Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.School of Medical Laboratory ScienceHawassa University College of Medicine and Health SciencesHawassaEthiopia
  2. 2.Hawassa University Comprehensive Specialized HospitalHawassaEthiopia

Personalised recommendations